Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space

Logos Biosystems releases new electrophoretic tissue clearing system with twice the features in half the space

Logos Biosystems has released the latest system for electrophoretic tissue clearing, the X-CLARITY™ Tissue Clearing System II. The new system has been upgraded with new features that make it streamlined, easier to use and more intuitive.

The X-CLARITY II is a compact, all-in-one, solution for convenient, rapid and electrophoretic tissue clearing (ETC). The system provides excellent transparency and is compatible with multiple tissue types and sizes, including hard tissues such as bone. Enabling preparation of whole tissues for analysis, the X-Clarity II saves users having to waste valuable time on the preparation, sectioning, labeling and mounting of hundreds of ultra-thin tissue slices.

A new ETC tower has replaced the previous ETC controller and pump and the system is neatly contained, with the ETC chamber and buffer reservoir sitting in a custom tray.

Benchtop space is always at a premium in the lab, since more space means more equipment can be made available for users to expand their research. With this in mind, the sleek X-CLARITY II has been designed to halve the system’s footprint.

The X-CLARITY II boasts increased functionality, featuring both active and passive tissue clearing modes rather than just the one active mode.  Researchers can choose from multiple options to tailor the clearing mode to their sample.

In the passive clearing mode, users can define up to three different cycles, where time, pump speed and clearing temperatures can all be precisely set. In the active mode, the X-CLARITY II can be set to apply a constant current or voltage.

The introduction of an easy-to-use, interactive touchscreen interface to replace the buttons that were previously used, means operators can now control the entire system and all its settings in an intuitive and straightforward manner.

Graphic onscreen readouts of the clearing conditions can be displayed in real time, including, temperature, voltage and current. These can also be exported to maintain quality control and keep a record of the clearing procedures and parameters that have previously been run.

Since the ETC process generates a lot of heat, Logos Biosystems has integrated a buffer temperature control module in the control tower to replace the small cooling system that was previously in the chamber. Buffer circulates in the tower, heating or cooling the solution as required, before it passes through to the chamber.

The new temperature control system allows much faster and more precise temperature setting, providing researchers with peace of mind. The extra equipment that may previously have been needed to ensure samples are kept at the right temperature is no longer required.

X-CLARITY II Tissue Clearing Applications

Tissue clearing provides users with a way of producing high-fidelity 3D images of their samples, without damaging or altering the underlying structure of the organic matter.

The X-CLARITY Tissue Clearing System is currently being used for the DataBrain project at the Centro E Piaggio in Pisa, Italy to develop a high-fidelity map of the brain using data of the neurons in their native 3D arrangement.

It is also being used in support of regenerative spinal cord research at the École polytechnique fédérale de Lausanne (EPFL) in Lausanne, Switzerland, where the X-CLARITY clearing technique was used to model severe spinal cord injuries in rodents. A severe contusion abolished all motor cortex projections below injury, which led to paralysis.

However, electrochemical neuromodulation therapy reinforced these projections and the motor cortex immediately regained adaptive control over the paralyzed legs. Reorganization of the circuit mediated a motor cortex-dependent recovery of walking and swimming without neuromodulation being required.

At INSERM (National Institute of Health and Medical Research) in Lyon, France, the X-CLARITY has been used to investigate the molecular mechanisms that control cell death during ischemia-reperfusion.

Logos Biosystems

Logos Biosystems

Logos Biosystems is dedicated to the development and commercialization of innovative technologies to support the life science research community. Since 2008, Logos Biosystems has been developing a series of automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

Tagged with:

About author

Related Articles